Article
A double-edged sword: Should stage IV non-small cell lung cancer patients be informed of their cancer diagnosis?
European journal of cancer care - 1 Nov 2017
Yanwei L, Dongying L, Zhuchen Y, Ling L, Yu Z, Zhanyu P
Abstract excerpt
This study aimed to examine whether awareness of cancer diagnosis and prognosis among patients with stage IV lung cancer treated with first-line erlotinib vary with psychological distress and quality of life (QoL). This study was carried out at the Comprehensive treatment Department of Tianjin Cancer Hospital between August 2013 and September 2015 among patients ≥18 years-old and suffering from EGFR...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
